Figures computed from official regulatory filings — .
Ownershipinsiders 1.69% · institutions 0% · short 1.2% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for ACURA PHARMACEUTICALS, INC only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc. and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was formerly known as Halsey Drug Co., Inc. The company was incorporated in 1935 and is based in Palatine, Illinois. Acura Pharmaceuticals, Inc. operates as a subsidiary of Abuse Deterrent Pharma, LLC.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
67 buys218 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| SKELLY WILLIAM G | Exercise | n/a (No price was disclosed in the filing) | SEC | ||
| THANGARAJ IMMANUELtrack record |
| AwardD (derivative) |
| n/a (No price was disclosed in the filing) |
| SEC |
| SKELLY WILLIAM G | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| ROSS GEORGE K | Exercise | n/a (No price was disclosed in the filing) | SEC |
| ROSS GEORGE K | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| THANGARAJ IMMANUELtrack record | Exercise | n/a (No price was disclosed in the filing) | SEC |
| ROSS GEORGE K | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| SKELLY WILLIAM G | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| THANGARAJ IMMANUELtrack record | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| THANGARAJ IMMANUELtrack record | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| THANGARAJ IMMANUELtrack record | Exercise | n/a (No price was disclosed in the filing) | SEC |
| THANGARAJ IMMANUELtrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| SKELLY WILLIAM G | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| SKELLY WILLIAM G | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| ROSS GEORGE K | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| ROSS GEORGE K | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| ROSS GEORGE K | Exercise | n/a (No price was disclosed in the filing) | SEC |
| SKELLY WILLIAM G | Exercise | n/a (No price was disclosed in the filing) | SEC |
| ROSS GEORGE K | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| ROSS GEORGE K | Exercise | n/a (No price was disclosed in the filing) | SEC |
| THANGARAJ IMMANUELtrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| WESSON BRUCE Ftrack record | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| WESSON BRUCE Ftrack record | Exercise | n/a (No price was disclosed in the filing) | SEC |
| ROSS GEORGE K | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| SKELLY WILLIAM G | Exercise | n/a (No price was disclosed in the filing) | SEC |